OR WAIT null SECS
October 17, 2024
Through the collaboration, Merck will use Mestag’s proprietary RAFT platform to investigate the pathogenic role that fibroblasts play in inflammatory diseases.
The new center's design will prioritize integration of the entire supply chain, with the aim of accelerating product development and autonomous production capacity in alignment with EU priorities.
October 12, 2024
Evonik's plant-based squalene, PhytoSquene, used in parenteral drug delivery applications, won the CPHI Excellence in Pharma Award in the “Sustainability” category.
October 11, 2024
This year's CPHI award winners emphasize achievements in pharma excellence.
October 03, 2024
How the Republican and Democrat presidential candidates might appeal to voters on this topic is starting to be seen.
September 28, 2024
Innovative solutions are making personalized cell and gene therapies accessible to all.
September 24, 2024
Emerging therapies, such as cell and gene therapies, come with unique challenges that must be planned for in advance.
September 18, 2024
Lilly has increased its manufacturing investment for biologics in Limerick, Ireland, by $1 billion while launching its new $800 million facility in Kinsale.
September 11, 2024
The finalists for the 2024 CPHI Pharma Awards are spread across 14 categories, which include future leaders, women of the year, and an “at the heart of pharma” category.
August 27, 2024
With the completion of its acquisition of Morphic, Lilly expands its immunology pipeline to include Morphic's oral integrin therapies to address inflammatory bowel disease.